Outputs (71)

Anticholinergic drugs and risk of dementia: Time for action? (2021)
Journal Article
Bell, B., Avery, A., Bishara, D., Coupland, C., Ashcroft, D., & Orrell, M. (2021). Anticholinergic drugs and risk of dementia: Time for action?. Pharmacology Research and Perspectives, 9(3), Article e00793. https://doi.org/10.1002/prp2.793

Evidence suggests that the prescription of bladder anticholinergics is increasing. Recent studies have accentuated concerns about whether certain prescribed medications could increase risk of dementia, including anticholinergic drugs, and specificall... Read More about Anticholinergic drugs and risk of dementia: Time for action?.

The implementation, use and sustainability of a clinical decision support system for medication optimisation in primary care: A qualitative evaluation (2021)
Journal Article
Jeffries, M., Salema, N.-E., Laing, L., Shamsuddin, A., Sheikh, A., Avery, A., Chuter, A., Waring, J., & Keers, R. (2021). The implementation, use and sustainability of a clinical decision support system for medication optimisation in primary care: A qualitative evaluation. PLoS ONE, 16(5), Article e0250946. https://doi.org/10.1371/journal.pone.0250946

Background: The quality and safety of prescribing in general practice is important, Clinical decision support (CDS) systems can be used which present alerts to health professionals when prescribing in order to identify patients at risk of potentiall... Read More about The implementation, use and sustainability of a clinical decision support system for medication optimisation in primary care: A qualitative evaluation.

Should all pregnant women be offered testing for group B streptococcus? (2021)
Journal Article
Walker, K. F., Plumb, J., Gray, J., Thornton, J., Avery, A. J., & Daniels, J. P. (2021). Should all pregnant women be offered testing for group B streptococcus?. British Medical Journal, 373, Article n882. https://doi.org/10.1136/bmj.n882

From policy to patient: Using a socio-ecological framework to explore the factors influencing safe practice in UK primary care (2021)
Journal Article
Litchfield, I., Perryman, K., Campbell, S., Avery, A., Gill, P., & Greenfield, S. (2021). From policy to patient: Using a socio-ecological framework to explore the factors influencing safe practice in UK primary care. Social Science and Medicine, 277, Article 113906. https://doi.org/10.1016/j.socscimed.2021.113906

Background: The recent and rapid changes in the model of primary care delivery have led to an increased focus on patient safety in what is one of the most diverse and complex healthcare settings. However, previous initiatives have failed to deliver t... Read More about From policy to patient: Using a socio-ecological framework to explore the factors influencing safe practice in UK primary care.

The evaluation of an e-learning prescribing course for general practice (2021)
Journal Article
Salema, N.-E., Clement, N., Hysenagolli, R., Hibberd, R., Bell, B. G., Gookey, G., Avery, A., & Knox, R. (2021). The evaluation of an e-learning prescribing course for general practice. Education for Primary Care, 32(4), 219-225. https://doi.org/10.1080/14739879.2021.1874250

Prescribed medication may lead to significant morbidity or mortality as a result of these medications causing adverse events, or because of a prescribing error. E-learning is a common tool used in supporting training in prescribing. This paper descri... Read More about The evaluation of an e-learning prescribing course for general practice.

Identifying anticholinergic burden in clinical practice (2021)
Journal Article
Bell, B., & Avery, A. (2021). Identifying anticholinergic burden in clinical practice. Prescriber, 32(3), 20-23. https://doi.org/10.1002/psb.1901

Anticholinergic medications are associated with a wide range of adverse effects to which elderly patients are particularly susceptible. This article discusses the various ways that anticholinergic burden can be measured, how these can be used to help... Read More about Identifying anticholinergic burden in clinical practice.

Effects of non-pharmacological interventions as vaccine adjuvants in humans: a systematic review and network meta-analysis (2020)
Journal Article
Vedhara, K., Royal, S., Sunger, K., Caldwell, D. M., Halliday, V., Taylor, C. M., Fairclough, L., Avery, A., & Welton, N. J. (2021). Effects of non-pharmacological interventions as vaccine adjuvants in humans: a systematic review and network meta-analysis. Health Psychology Review, 15(2), 245-271. https://doi.org/10.1080/17437199.2020.1854050

© 2020 Informa UK Limited, trading as Taylor & Francis Group. Introduction: Psychological and behavioural may enhance vaccine effectiveness. We conducted a systematic review and network meta-analysis (NMA) to examine the effects of non-pharmacologi... Read More about Effects of non-pharmacological interventions as vaccine adjuvants in humans: a systematic review and network meta-analysis.

Incidence, nature and causes of avoidable significant harm in primary care in England: retrospective case note review (2020)
Journal Article
Avery, A. J., Sheehan, C. L., Bell, B. G., Armstrong, S. J., Ashcroft, D. M., Boyd, M. J., Chuter, A., Cooper, A., Donnelly, A., Edwards, A., Prosser Evans, H., Hellard, S., Lymn, J., Mehta, R., Rodgers, S., Sheikh, A., Smith, P., Williams, H., Campbell, S., & Carson-Stevens, A. (2021). Incidence, nature and causes of avoidable significant harm in primary care in England: retrospective case note review. BMJ Quality and Safety, 30(12), 961-976. https://doi.org/10.1136/bmjqs-2020-011405

Objective To estimate the incidence of avoidable significant harm in primary care in England; describe and classify the associated patient safety incidents and generate suggestions to mitigate risks of ameliorable factors contributing to the incident... Read More about Incidence, nature and causes of avoidable significant harm in primary care in England: retrospective case note review.

Preventable medication harm across health care settings: a systematic review and meta-analysis (2020)
Journal Article
Hodkinson, A., Tyler, N., Ashcroft, D. M., Keers, R. N., Khan, K., Phipps, D., Abuzour, A., Bower, P., Panagioti, M., Avery, A., & Campbell, S. (2020). Preventable medication harm across health care settings: a systematic review and meta-analysis. BMC Medicine, 18(1), Article 313. https://doi.org/10.1186/s12916-020-01774-9

Background: Mitigating or reducing the risk of medication harm is a global policy priority. But evidence reflecting preventable medication harm in medical care and the factors that derive this harm remain unknown. Therefore, we aimed to quantify the... Read More about Preventable medication harm across health care settings: a systematic review and meta-analysis.

Evaluation of a pharmacist-led actionable audit and feedback intervention for improving medication safety in UK primary care: An interrupted time series analysis (2020)
Journal Article
Peek, N., Gude, W. T., Keers, R. N., Williams, R., Kontopantelis, E., Jeffries, M., Phipps, D. L., Brown, B., Avery, A. J., & Ashcroft, D. M. (2020). Evaluation of a pharmacist-led actionable audit and feedback intervention for improving medication safety in UK primary care: An interrupted time series analysis. PLoS Medicine, 17(10), Article e1003286. https://doi.org/10.1371/journal.pmed.1003286

Background: We evaluated the impact of the pharmacist-led Safety Medication dASHboard (SMASH) intervention on medication safety in primary care.

Methods and findings: SMASH comprised (1) training of clinical pharmacists to deliver the intervention... Read More about Evaluation of a pharmacist-led actionable audit and feedback intervention for improving medication safety in UK primary care: An interrupted time series analysis.